Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin
US6123961A · kind A · utility
27Cited by
3References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 23, 1997 |
| Grant date | Sep 26, 2000 |
| Priority date | — |
| Expiry date | Sep 23, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating or preventing urinary incontinence and other motility disorders involving the urethrogenital tract, by administering to a mammal an effective amount of the R-isomers of 4-diethylamino-2-butynyl cyclohexylphenylglycolate and 4-ethylamino-2-butynyl cyclohexylphenylglycolate and pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.